BRAINSTORM CELL THERAPEUTICS INC. Grants Receivable, Current
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Grants Receivable, Current of $574.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Notes › Nontrade Receivables › Nontrade Receivables, Current
us-gaap:GrantsReceivableCurrent · last filed 2018-03-08
- 2017-12-31: Grants Receivable, Current $574.00K.
- 2016-12-31: Grants Receivable, Current $154.00K.
- 2015-12-31: Grants Receivable, Current $607.00K.
- 2014-12-31: Grants Receivable, Current $962.00K.
| Period end | Grants Receivable, Current |
|---|---|
| 2017-12-31 | $574.00K 10-K · filed 2018-03-08 |
| 2016-12-31 | $154.00K 10-K · filed 2018-03-08 |
| 2015-12-31 | $607.00K 10-K · filed 2017-03-29 |
| 2014-12-31 | $962.00K 10-K · filed 2016-03-09 |
| 2013-12-31 | $850.00K 10-K · filed 2015-03-26 |
| 2012-12-31 | $634.00K 10-K · filed 2014-03-27 |
| 2011-12-31 | $236.00K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |